Semaglutide and tirzepatide were first used to help type 2 diabetes patients regulate their blood-sugar levels.
But in the past three to four years, they started being prescribed as a weight-loss aide, leading to global shortages and counterfeit products.
Both are given as weekly injections via pre-filled pens self-administered into the upper arm, thigh or stomach.
And patients generally start on a low dose, which is gradually increased.
The drugs mimic the intestinal hormone glucagon-like peptide-1 (GLP-1), which is released after eating and typically makes people feel fuller.
Tirzepatide (Mounjaro) also affects the glucose-dependent insulinotropic polypeptide (GIP) hormone, which controls metabolism and helps regulate energy balance.
The first study into weight-loss drugs has found they can significantly improve heart health, with lower levels of heart attacks, stroke, heart failure and high blood pressure.
RIYADH: By the 17th minute, it seemed as if Al-Ahli were braced for a high-scoring…
NEW YORK CITY: The UN Security Council on Friday reaffirmed its backing for the UN’s…
PARIS: Former French Prime Minister Dominique de Villepin announced his candidacy for president on Friday,…
VILNIUS: Estonia will close its road border crossings with Russia on security grounds for at…
PARIS: A cargo ship flying the Maltese flag ran aground off the coast of the…
NOWA DEBA, Poland: Thousands of European troops are taking part in an unprecedented military exercise…